NO154131B - ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOSTYRIC DERIVATIVES. - Google Patents

ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOSTYRIC DERIVATIVES. Download PDF

Info

Publication number
NO154131B
NO154131B NO792659A NO792659A NO154131B NO 154131 B NO154131 B NO 154131B NO 792659 A NO792659 A NO 792659A NO 792659 A NO792659 A NO 792659A NO 154131 B NO154131 B NO 154131B
Authority
NO
Norway
Prior art keywords
group
general formula
butoxy
nitro
melting point
Prior art date
Application number
NO792659A
Other languages
Norwegian (no)
Other versions
NO154131C (en
NO792659L (en
Inventor
Erich Mueller
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO792659L publication Critical patent/NO792659L/en
Publication of NO154131B publication Critical patent/NO154131B/en
Publication of NO154131C publication Critical patent/NO154131C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06Preparation of nitro compounds
    • C07C201/12Preparation of nitro compounds by reactions not involving the formation of nitro groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms

Description

I patent 152839 (ansøkning 79.0521) er beskrevet frem-gangsmåter for fremstilling av bl.a. karbostyrilderivater med den generelle formel In patent 152839 (application 79.0521) procedures for the production of, among other things, are described. carbostyryl derivatives of the general formula

hvor where

W betyr en eventuelt med en metylgruppe substituert vinylen- W means a vinylene optionally substituted with a methyl group-

gruppe eller en etylengruppe, group or an ethylene group,

m betyr tallet 0, 1 eller 2, m means the number 0, 1 or 2,

D betyr en lineær alkylengruppe med 2 til 6 karbonatomer, en 2-hydroksy-n-propylengruppe eller en xylylengruppe, D means a linear alkylene group of 2 to 6 carbon atoms, a 2-hydroxy-n-propylene group or a xylylene group,

R2 betyr en cykloheksy1-, benzyl-, naftyl-, pyridyl-, pyrimidyl-, 1,2,4-triazolyl-, pyridyl-oksyd-, furfuryl-, trifenylmetyl-, R 2 means a cyclohexy1-, benzyl-, naphthyl-, pyridyl-, pyrimidyl-, 1,2,4-triazolyl-, pyridyl-oxide-, furfuryl-, triphenylmethyl-,

kinolyl-, benzimidazolyl-, benztiazolyl-, kinazolin-4-on-yl-, 4,5-bis- (p-klorfenyl)-oksazol-2-yl-, N-metyl-N-cykloheksylamino-karbonylmety1- eller aminoiminometylgruppe, en eventuelt med en karboksyl-, hydroksy-, metoksy-, amino-, acetylamino-, nitro-, cykloheksyl- eller fenylgruppe substituert fenylgruppe, quinolyl-, benzimidazolyl-, benzthiazolyl-, quinazolin-4-on-yl-, 4,5-bis-(p-chlorophenyl)-oxazol-2-yl-, N-methyl-N-cyclohexylamino-carbonylmethyl- or aminoiminomethyl group, a phenyl group optionally substituted with a carboxyl, hydroxy, methoxy, amino, acetylamino, nitro, cyclohexyl or phenyl group,

en med halogenatomer og/eller alkylgrupper med 1-4 karbonatomer mono- eller disubstituert fenylgruppe, en med to halogenatomer eller med to alkylgrupper med 1-4 karbonatomer substituert one with halogen atoms and/or alkyl groups with 1-4 carbon atoms mono- or disubstituted phenyl group, one with two halogen atoms or with two alkyl groups with 1-4 carbon atoms substituted

hydroksyfenyl-, halogenfenyl- eller aminofenylgruppe, hydroxyphenyl, halophenyl or aminophenyl group,

R^ betyr et hydrogen- eller bromatom eller en acetylamino- eller nitrogruppe, og R^ means a hydrogen or bromine atom or an acetylamino or nitro group, and

resten R„-S0 -D-0- er i 6- eller 7-stilling. the remainder R„-S0 -D-0- is in the 6- or 7-position.

/ m J/ m J

Forbindelsene med den ovenstående generelle formel The compounds with the above general formula

I oppviser verdifulle terapeutiske egenskaper, ved siden av en positiv inotrop virkning, særlig anti trombotiske egenskaper, slik som vist i hovedpatentet. In addition to a positive inotropic effect, it exhibits valuable therapeutic properties, particularly anti-thrombotic properties, as shown in the main patent.

Det er nu funnet at karbostyrilderivatene med den generelle formel I også kan fremstilles efter følgende frem-gangmåter: a) Ringslutning av en eventuelt i reaksjonsblandingen dannet forbindelse med den generelle formel It has now been found that the carbostyryl derivatives with the general formula I can also be prepared according to the following procedures: a) Ring closure of a possibly in the reaction mixture formed connection with the general formula

hvor where

D, W, R2' R3 og m er som ovenfor angitt, og D, W, R2, R3 and m are as indicated above, and

Z betyr en nukleofil, avspaltbar gruppe så som en hydroksygruppe, et halogenatom, en alkoksy-, aryloksy- eller aralkoksygruppe. Z means a nucleophilic leaving group such as a hydroxy group, a halogen atom, an alkoxy, aryloxy or aralkyl group.

Ringslutningen foretas fortrinnsvis i nærvær av et kondensasjonsmiddel så som svovelsyre, konsentrert saltsyre, fosforsyre eller tionylklorid, hensiktsmessig i et oppløsnings-middel så som iseddik, tetrahydrofuran, dioksan, kloroform, toluen, etanol eller et overskudd av det anvendte kondensasjonsmiddel ved forhøyet temperatur, f.eks. ved temperaturer mellom 50 og 200°C, fortrinnsvis ved temperaturer mellom 80 og 150°C. Omsetningen kan imidlertid også utføres uten oppløsningsmiddel og/eller kondensasjonsmiddel. The cyclization is preferably carried out in the presence of a condensing agent such as sulfuric acid, concentrated hydrochloric acid, phosphoric acid or thionyl chloride, suitably in a solvent such as glacial acetic acid, tetrahydrofuran, dioxane, chloroform, toluene, ethanol or an excess of the used condensing agent at an elevated temperature, f .ex. at temperatures between 50 and 200°C, preferably at temperatures between 80 and 150°C. However, the reaction can also be carried out without solvent and/or condensing agent.

Det er her ikke nødvendig å isolere en som utgangs-materiale anvendt forbindelse med den generelle formel II. It is not necessary here to isolate a compound of the general formula II used as starting material.

Denne kan snarere fremstilles in situ fra den tilsvarende nitroforbindelse, f.eks. ved reduksjon av nitrogruppen med hydrogen i nærvær av en hydrogeneringskatalysator så som palladium/kull, palladium/kalsiumkarbonat eller palladium/kalsiumkarbonat + blyacetat (Lindlar-katalysator), ved reduksjon med metaller så This can rather be prepared in situ from the corresponding nitro compound, e.g. by reduction of the nitro group with hydrogen in the presence of a hydrogenation catalyst such as palladium/charcoal, palladium/calcium carbonate or palladium/calcium carbonate + lead acetate (Lindlar catalyst), by reduction with metals such

som jern, tinn eller sink i nærvær av en syre, ved reduksjon med salter så som jern(II)sulfat, tinn(II)klorid, krom(II)klorid eller natriumditionitt eller ved reduksjon med hydrazin i nærvær av Raney-nikkel. such as iron, tin or zinc in the presence of an acid, by reduction with salts such as iron(II) sulphate, tin(II) chloride, chromium(II) chloride or sodium dithionite or by reduction with hydrazine in the presence of Raney nickel.

Hvis m i en tilsvarende nitroforbindelse betyr tallet 1, foretas reduksjonen av nitrogruppen hensiktsmessig med den ekvivalente mengde av det anvendte reduksjonsmiddel, f.eks. If m in a corresponding nitro compound means the number 1, the reduction of the nitro group is suitably carried out with the equivalent amount of the reducing agent used, e.g.

med et metallsalt så som jern(II)sulfat, tinn(II)klorid, krom(II)-klorid eller natriumditionitt, eller med hydrogen i nærvær av en desaktivert hydrogeneringskatalysator, f.eks. i nærvær av palladium/kalsiumkarbonat + blyacetat. Hvis man f.eks. foretar reduksjonen i nærvær av palladium/kull, vil sulfoksydgruppen delvis bli medredusert. with a metal salt such as iron (II) sulfate, stannous (II) chloride, chromium (II) chloride or sodium dithionite, or with hydrogen in the presence of a deactivated hydrogenation catalyst, e.g. in the presence of palladium/calcium carbonate + lead acetate. If you e.g. if the reduction is carried out in the presence of palladium/charcoal, the sulfoxide group will be partially co-reduced.

Hvis W i den tilsvarende nitroforbindelse dessuten Moreover, if W in the corresponding nitro compound

betyr en vinylengruppe, kan denne gruppe, særlig når reduksjonen foretas med katalytisk aktivert hydrogen, f.eks. med hydrogen i nærvær av palladium/kull, hydrogeneres til den tilsvarende etylengruppe. b) For fremstilling av forbindelser med den generelle formel I hvor m betyr tallet 2: means a vinylene group, this group can, especially when the reduction is carried out with catalytically activated hydrogen, e.g. with hydrogen in the presence of palladium/charcoal, is hydrogenated to the corresponding ethylene group. b) For the preparation of compounds of the general formula I where m means the number 2:

Omsetning av et karbostyril med den generelle formel Reaction of a carbostyril with the general formula

hvor D, W og R3 er som ovenfor angitt, og where D, W and R 3 are as above indicated, and

Y betyr en nukleofil, avspaltbar gruppe så som et halogenatom eller en sulfonsyrerest, f.eks. et klor-, brom- eller jodatom, en p-toluensulfonyloksy- eller metansulfonyloksygruppe, med et metallsalt med den generelle formel Y means a nucleophilic, cleavable group such as a halogen atom or a sulphonic acid residue, e.g. a chlorine, bromine or iodine atom, a p-toluenesulfonyloxy or methanesulfonyloxy group, with a metal salt of the general formula

hvor R_ er som ovenfor angitt, og where R_ is as above indicated, and

Me betyr et alkali- metallatom, og Me^ betyr et jordalkali-metallatom så som henholdsvis et natrium- eller kaliumatom eller et kalsiumatom. Me means an alkali metal atom, and Me^ means an alkaline earth metal atom such as a sodium or potassium atom or a calcium atom, respectively.

Omsetningen foretas hensiktsmessig i et egnet oppløsnings-middel så som dioksan, tetrahydrofuran, kloroform eller toluen, fortrinnsvis i et vandig aprotisk oppløsningsmiddel så som aceton, dimetylformamid eller dimetylsulfoksyd, eventuelt i nærvær av en alkalibase så som natriumkarbonat, kaliumkarbonat eller natriumhydroksyd ved temperaturer mellom 0°C og det anvendte oppløsningsmiddels koketemperatur, f.eks. ved temperaturer mellom 0 og 100°C, fortrinnsvis ved temperaturer mellom 10 og 50°C. Omsetningen kan også utføres uten oppløsningsmiddel. c) For fremstilling av forbindelser med den generelle formel I hvor W betyr en vinylengruppe og m betyr tallet 0 eller 2: Ringslutning av en eventuelt i reaksjonsblandingen dannet forbindelse med den generelle formel The reaction is conveniently carried out in a suitable solvent such as dioxane, tetrahydrofuran, chloroform or toluene, preferably in an aqueous aprotic solvent such as acetone, dimethylformamide or dimethylsulfoxide, optionally in the presence of an alkali base such as sodium carbonate, potassium carbonate or sodium hydroxide at temperatures between 0 °C and the boiling temperature of the solvent used, e.g. at temperatures between 0 and 100°C, preferably at temperatures between 10 and 50°C. The reaction can also be carried out without a solvent. c) For the preparation of compounds with the general formula I where W means a vinylene group and m means the number 0 or 2: Ring closure of an optionally in the reaction mixture formed connection with the general formula

hvor & 2' R3' D og m er som ovenfor angitt, eller et acetal derav. where & 2' R 3' D and m are as indicated above, or an acetal thereof.

Ringslutningen foretas hensiktsmessig i iseddik eller eddiksyreanhydrid i nærvær av et alkaliacetat så som natrium-eller kaliumacetat ved temperaturer mellom 80 og 160°C, fortrinnsvis ved reaksjonsblandingens koketemperatur, f.eks. ved temperaturer mellom 118 og 140°C. En forbindelse med den generelle formel V fremstilles hensiktsmessig ved reduksjon av en tilsvarende nitroforbindelse i nærvær av acetylklorid eller eddiksyreanhydrid, og det er ikke nødvendig å isolere den. The cyclization is suitably carried out in glacial acetic acid or acetic anhydride in the presence of an alkali acetate such as sodium or potassium acetate at temperatures between 80 and 160°C, preferably at the boiling temperature of the reaction mixture, e.g. at temperatures between 118 and 140°C. A compound of the general formula V is conveniently prepared by reduction of a corresponding nitro compound in the presence of acetyl chloride or acetic anhydride, and it is not necessary to isolate it.

De som utgangsmaterialer anvendte forbindelser med Those used as starting materials compounds with

de generelle formler II til Vier delvis kjent fra litteraturen eller kan fremstilles ved i og for seg kjente metoder. the general formulas II to Vier are partially known from the literature or can be prepared by methods known per se.

Således får man en forbindelse med den generelle Thus one gets a connection with the general

formel II ved reduksjon av den tilsvarende nitroforbindelse, formula II by reduction of the corresponding nitro compound,

som man på sin side får ved alkylering av en tilsvarende 2-nitro-5-hydroksyforbindelse med et tilsvarende a,w-dihalogenalkan, påfølgende omsetning med en tilsvarende merkaptoforbindelse og eventuelt påfølgende oksydasjon med hydrogenperoksyd. which in turn is obtained by alkylation of a corresponding 2-nitro-5-hydroxy compound with a corresponding a,w-dihaloalkane, subsequent reaction with a corresponding mercapto compound and possibly subsequent oxidation with hydrogen peroxide.

En utgangsforbindelse med den generelle formel III A starting compound of the general formula III

får man ved omsetning av et tilsvarende hydroksykarbostyril med et tilsvarende alkan som er substituert i a,oo-stilling. Det nødvendige tilsvarende 6-, 7- eller 8-hydroksy-3,4-dihydrokarbostyril får man ved acylering av et tilsvarende anilinderivat med et tilsvarende 3-halogen-karboksylsyrederivat og påfølgende ringslutning ifølge Friedel-Crafts (se J. chem. Soc. 1955, 743-744, Chem. Pharm. Bull 1961, 970-975 og Ber. dtsch. Chem. Ges. 60, 858 (1927)) resp. et 5-hydroksy-3,4-dihydrokarbostyril ved ringslutning av et tilsvarende 2-(3-cyanoetyl)-cykloheksandion-1,3-derivat og påfølgende aromatisering, f.eks. med N-brom-succinimid (se Chem. and Ind. 1970, 1435). Fremstillingen av de nødvendige hydroksy-karbostyriler er kjent fra litteraturen is obtained by reacting a corresponding hydroxycarbostyryl with a corresponding alkane that is substituted in the a,oo position. The necessary corresponding 6-, 7- or 8-hydroxy-3,4-dihydrocarbostyryl is obtained by acylation of a corresponding aniline derivative with a corresponding 3-halocarboxylic acid derivative and subsequent ring closure according to Friedel-Crafts (see J. chem. Soc. 1955 , 743-744, Chem. Pharm. Bull 1961, 970-975 and Ber. dtsch. Chem. Ges. 60, 858 (1927)) resp. a 5-hydroxy-3,4-dihydrocarbostyril by cyclization of a corresponding 2-(3-cyanoethyl)-cyclohexanedione-1,3-derivative and subsequent aromatization, e.g. with N-bromosuccinimide (see Chem. and Ind. 1970, 1435). The production of the necessary hydroxycarbostyrils is known from the literature

(se f.eks. J. Amer. Chem. Soc. 12, 346 (1950) og ibid 16, 2402 (see, e.g., J. Amer. Chem. Soc. 12, 346 (1950) and ibid 16, 2402

(1954) resp. J. Org. Chem. 3^3, 1089 (1968) og ibid 36 , 3493 (1954) or J. Org. Chem. 3^3, 1089 (1968) and ibid 36 , 3493

(1971) ) . (1971) ).

En som utgangsforbindelse anvendt forbindelse med den generelle formel V får man f.eks. ved alkylering av et tilsvarende hydroksy-nitro-benzaldehyd resp. dets acetal eller ester med et tilsvarende halogenid og påfølgende reduksjon av nitrogruppen i nærvær av eddiksyreanhydrid. A compound with the general formula V used as starting compound gives, for example, by alkylation of a corresponding hydroxy-nitro-benzaldehyde resp. its acetal or ester with a corresponding halide and subsequent reduction of the nitro group in the presence of acetic anhydride.

De følgende eksempler skal tjene til å illustrere opp-finnelsen ytterligere. The following examples shall serve to further illustrate the invention.

Eksempel 1 Example 1

6-[ 4- ( 2- pyridylsulfonyl)- butoksy]- 3, 4- dihydrokarbostyril 6-[ 4-( 2- pyridylsulfonyl)- butoxy]- 3, 4- dihydrocarbostyril

a) 2- nitro- 5- hydroksy- kanelsyre- metylester a) 2-nitro-5-hydroxy-cinnamic acid methyl ester

21,0 g 2-nitro-5-hydroksy-kanelsyre (S. N. Chakravarti og 21.0 g of 2-nitro-5-hydroxycinnamic acid (S. N. Chakravarti and

P.L.N. Rao, Chem. Soc. 1938, 172) oppløses i 200 ml metanol og tilsettes dråpevis 86 ml tionylklorid under omrøring i løpet av 45 minutter, hvorved temperaturen stiger til 36°C. Man efter-rører i ytterligere 25 minutter. Efter avkjøling i isbad får man 18,6 g 2-nitro-5-hydroksy-kanelsyremetylester med smeltepunkt 201-203°C. P.L.N. Rao, Chem. Soc. 1938, 172) is dissolved in 200 ml of methanol and 86 ml of thionyl chloride is added dropwise with stirring over the course of 45 minutes, whereby the temperature rises to 36°C. You continue to stir for a further 25 minutes. After cooling in an ice bath, 18.6 g of 2-nitro-5-hydroxycinnamic acid methyl ester with a melting point of 201-203°C is obtained.

b) 2- nitro- 5- brombutoksy- kanelsyre- metylester b) 2-nitro-5-bromobutoxy-cinnamic acid methyl ester

22,3 g 2-nitro-5-hydroksy-kanelsyre-metylester omrøres 22.3 g of 2-nitro-5-hydroxycinnamic acid methyl ester are stirred

med 59,7 ml 1,4-dibrombutan og 13,8 g kaliumkarbonat i 200 ml dimetylsulfoksyd i 15 timer ved romtemperatur, hvorefter 800 ml vann tilsettes. Man ekstraherer med kloroform, og efter avdampning av oppløsningsmidlet isoleres 31,7 g 2-nitro-5-brombutoksy-kanelsyre-metylester med smeltepunkt 60,5-63°C. with 59.7 ml of 1,4-dibromobutane and 13.8 g of potassium carbonate in 200 ml of dimethylsulfoxide for 15 hours at room temperature, after which 800 ml of water is added. It is extracted with chloroform, and after evaporation of the solvent, 31.7 g of 2-nitro-5-bromobutoxycinnamic acid methyl ester with a melting point of 60.5-63°C is isolated.

c) 2- nitro- 5-[ 4-( 2- pyridylmerkapto)- butoksy]- kanelsyre- metylester 10,75 g 2-nitro-5-brombutoksy-kanelsyre-metylester c) 2-nitro-5-[4-(2-pyridylmercapto)-butoxy]-cinnamic acid methyl ester 10.75 g 2-nitro-5-bromobutoxy-cinnamic acid methyl ester

settes til en blanding av 5 g kaliumkarbonat og 4,0 g 2-merkaptopyridin i 100 ml dimetylsulfoksyd som på forhånd er omrørt i 60 minutter, og man omrører i 18 timer ved romtemperatur. Man tilsetter 400 ml vann og isolerer det oljeaktige reaksjonsprodukt ved eterekstråksjon. is added to a mixture of 5 g of potassium carbonate and 4.0 g of 2-mercaptopyridine in 100 ml of dimethylsulfoxide which has been stirred for 60 minutes in advance, and is stirred for 18 hours at room temperature. 400 ml of water is added and the oily reaction product is isolated by ether extraction.

Utbytte: 11,0 g (94,2% av det teoretiske). Yield: 11.0 g (94.2% of theoretical).

d) 2- nitro- 5-[ 4- ( 2- pyridylsulfonyl)- butoksy]- kanelsyre- metylester 7,0 g 2-nitro-5-[4-(2-pyridylmerkapto)-butoksy]-kanelsyre-metylester oppløses i 70 ml eddiksyre, tilsettes 5,0 ml 35%ig hydrogenperoksyd og får stå i 3 dager ved romtemperatur. Efter avdestillering av iseddiken omkrystalliserer man produktet fra kloroform/metanol. d) 2-nitro-5-[4-(2-pyridylsulfonyl)-butoxy]-cinnamic acid methyl ester Dissolve 7.0 g of 2-nitro-5-[4-(2-pyridylmercapto)-butoxy]-cinnamic acid methyl ester in 70 ml of acetic acid, 5.0 ml of 35% hydrogen peroxide is added and allowed to stand for 3 days at room temperature. After distilling off the glacial acetic acid, the product is recrystallized from chloroform/methanol.

Utbytte: 3,5 g (46,2% av det teoretiske), smeltepunkt: 118-121°C. Yield: 3.5 g (46.2% of the theoretical), melting point: 118-121°C.

De ovenstående punkter a)-d) angår fremstilling av utgangs-materiale. The above points a)-d) relate to the production of starting material.

e) 6- [ 4- ( 2- pyridylsulfonyl)- butoksy]- 3, 4- dihydrokarbostyril e) 6- [ 4- ( 2- pyridylsulfonyl)- butoxy]- 3, 4- dihydrocarbostyril

2,1 g 2-nitro-5-[4-(2-pyridylsulfonyl)-butoksy]-kanelsyre-metylester , oppløst i 20 ml iseddik, hydrogeneres med 0,5 g 10%ig palladiumkull ved 3 bar hydrogentrykk og romtemperatur. Derefter avdestilleres iseddiken, og residuet oppvarmes med 20 ml konsentrert saltsyre i 4 timer til kokning under tilbakeløps-kjøling. Efter nøytralisering med 2N natronlut ekstraherer man med kloroform. Avdampningsresiduet omkrystalliseres fra xylen. Utbytte: 1,06 g (55,6% av det teoretiske), smeltepunkt: 121-123°C. 2.1 g of 2-nitro-5-[4-(2-pyridylsulfonyl)-butoxy]-cinnamic acid methyl ester, dissolved in 20 ml of glacial acetic acid, is hydrogenated with 0.5 g of 10% palladium charcoal at 3 bar hydrogen pressure and room temperature. The glacial acetic acid is then distilled off, and the residue is heated with 20 ml of concentrated hydrochloric acid for 4 hours to boiling under reflux cooling. After neutralization with 2N caustic soda, extraction is carried out with chloroform. The evaporation residue is recrystallized from xylene. Yield: 1.06 g (55.6% of theory), melting point: 121-123°C.

Eksempel 2 Example 2

6- [ 4- ( 2- pyridylsulfonyl)- butoksy]- karbostyril 6- [ 4- ( 2- pyridylsulfonyl)- butoxy]- carbostyryl

2,0 g 2-nitro-5-[4-(2-pyridylsulfonyl)-butoksy]-kanelsyre-metylester oppvarmes sammen med 3,0 g natriumditionitt i en blanding av 20 ml vann og 10 ml etanol i 4 timer til kokning under tilbakeløpskjøling, hvorved det dannes en klar oppløsning. Reaksjonsblandingen inndampes og oppvarmes med 20 ml konsentrert saltsyre i 3 timer til kokning under tilbakeløpskjøling. Efter nøytralisering med 2N natronlut ekstraheres reaksjonsproduktet med eter og omkrystalliseres fra xylen under tilsetning av litt dimetylformamid. 2.0 g of 2-nitro-5-[4-(2-pyridylsulfonyl)-butoxy]-cinnamic acid methyl ester is heated together with 3.0 g of sodium dithionite in a mixture of 20 ml of water and 10 ml of ethanol for 4 hours to boiling under reflux cooling, whereby a clear solution is formed. The reaction mixture is evaporated and heated with 20 ml of concentrated hydrochloric acid for 3 hours to boiling under reflux. After neutralization with 2N caustic soda, the reaction product is extracted with ether and recrystallized from xylene while adding a little dimethylformamide.

Utbytte: 0,5 g (29% av det teoretiske), smeltepunkt: 176-179°C. Yield: 0.5 g (29% of theoretical), melting point: 176-179°C.

På samme måte kan denne forbindelse fremstilles når man istedenfor natriumditionitt som reduksjonsmiddel anvender hydrogen i nærvær av Lindlar-katalysator (palladium, partielt inaktivert med bly). Derved reduseres bare nitrogruppen, slik at man efter den påfølgende behandling med konsentrert saltsyre får 6-[4-(2-pyridylsulfonyl)-butoksy]-karbostyril. In the same way, this compound can be prepared when, instead of sodium dithionite as reducing agent, hydrogen is used in the presence of a Lindlar catalyst (palladium, partially inactivated with lead). Thereby, only the nitro group is reduced, so that after the subsequent treatment with concentrated hydrochloric acid, 6-[4-(2-pyridylsulfonyl)-butoxy]-carbostyril is obtained.

Eksempel 3 Example 3

6-[ 4-( 3, 4- diklorfenylmerkapto)- butoksy]- karbostyril 6-[ 4-( 3, 4- dichlorophenylmercapto)- butoxy]- carbostyryl

4,5 g 2-nitro-5-[4-(3,4-diklorfenylmerkapto)-butoksy]-kanelsyre-metylester (smeltepunkt: 91-92°C; fremstilt fra 2-nitro-5-hydroksy-kanelsyre-metylester og 4-(3,4-diklorfenyl-merkapto) -butylbromid) oppvarmes til kokning under tilbakeløps-kjøling sammen med 13,9 g natriumditionitt i en blanding av 50 ml etanol og 50 ml vann i 4 timer. Derefter avdestillerer man oppløsningsmidlet og koker residuet under tilbakeløpskjøling i 4.5 g of 2-nitro-5-[4-(3,4-dichlorophenylmercapto)-butoxy]-cinnamic acid methyl ester (melting point: 91-92°C; prepared from 2-nitro-5-hydroxy-cinnamic acid methyl ester and 4-(3,4-dichlorophenyl-mercapto)-butyl bromide) is heated to boiling under reflux with 13.9 g of sodium dithionite in a mixture of 50 ml of ethanol and 50 ml of water for 4 hours. The solvent is then distilled off and the residue is boiled under reflux in

4 timer med 100 ml konsentrert saltsyre. Det dannede krystallinske 4 hours with 100 ml of concentrated hydrochloric acid. It formed crystalline

stoff avsuges og omkrystalliseres med xylen. substance is suctioned off and recrystallized with xylene.

Utbytte: 1,2 g (31% av det teoretiske), smeltepunkt: 144°C. Yield: 1.2 g (31% of theoretical), melting point: 144°C.

E ksempel 4 Example 4

6-[ 4- ( 3, 4- diklorfenylsulfonyl)- butoksy]- 3, 4- dihydro- karbostyril 6-[ 4-( 3, 4- dichlorophenylsulfonyl)- butoxy]- 3, 4- dihydro- carbostyryl

I 50 ml absolutt dimetylsulfoksyd omrøres 5,96 g 6-(4-brombutoksy)-3,4-dihydrokarbostyril sammen med 5,53 g kaliumkarbonat og 18,75 g 3,4-diklorfenylsulfinsurt natrium i 24 timer ved romtemperatur. Derefter opptas reaksjonsblandingen i 500 ml eddiksyreetylester, vaskes med vann og tørres over magnesiumsulfat. Ved inndampning av oppløsningen får man det krystallinske reaksjonsprodukt. In 50 ml of absolute dimethylsulfoxide, 5.96 g of 6-(4-bromobutoxy)-3,4-dihydrocarbostyril are stirred together with 5.53 g of potassium carbonate and 18.75 g of 3,4-dichlorophenylsulfinic acid sodium for 24 hours at room temperature. The reaction mixture is then taken up in 500 ml ethyl acetate, washed with water and dried over magnesium sulphate. When the solution is evaporated, the crystalline reaction product is obtained.

Utbytte: 4,65 g (54% av det teoretiske), smeltepunkt: 170-171°C. Yield: 4.65 g (54% of the theoretical), melting point: 170-171°C.

Eksempel 5 Example 5

6-[ 4-( 3, 4- diklorfenyl- sulfinyl)- butoksy]- karbostyril 6-[ 4-( 3, 4- dichlorophenyl- sulfinyl)- butoxy]- carbostyryl

a) 2- nitro- 5-[ 4- ( 3, 4- diklorfenylsulfinyl)- butoksy]- kanelsyre-metylester a) 2-nitro-5-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-cinnamic acid methyl ester

11,2 g 2-nitro-5-hydroksy-kanelsyre-metylester oppløses 11.2 g of 2-nitro-5-hydroxycinnamic acid methyl ester are dissolved

i 150 ml dimetylsulfoksyd og omrøres med 9,2 g vannfritt kaliumkarbonat i 15 minutter, hvorefter 16,5 g 4-(3,4-diklorfenyl-sulf inyl) -butylbromid tilsettes, og blandingen omrøres i 40 timer ved romtemperatur. Man fortynner med 1000 ml vann og ekstraherer med en blanding av 200 ml kloroform og 100 ml metanol. Efter avdampning av det organiske oppløsningsmiddel blir det tilbake et oljeaktig residuum som efter behandling med eter gjennom-krystalliserer. in 150 ml of dimethyl sulfoxide and stirred with 9.2 g of anhydrous potassium carbonate for 15 minutes, after which 16.5 g of 4-(3,4-dichlorophenyl-sulfinyl)-butyl bromide is added, and the mixture is stirred for 40 hours at room temperature. Dilute with 1000 ml of water and extract with a mixture of 200 ml of chloroform and 100 ml of methanol. After evaporation of the organic solvent, an oily residue remains which, after treatment with ether, crystallizes through.

Utbytte: 13 g (57% av det teoretiske), smeltepunkt: 78-81°C. Yield: 13 g (57% of theoretical), melting point: 78-81°C.

b) 2- amino- 5-[ 4-( 3, 4- diklorfenylsulfinyl)- butoksy]- kanelsyre-metylester b) 2-amino-5-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-cinnamic acid methyl ester

4,2'g 2-nitro-5-[4- (3,4-diklorfenylsulfinyl)-butoksy]-kanelsyremetylester hydrogeneres i 100 ml metanol med 0,5 g Lindlar-katalysator (palladium på kalsiumkarbonat, partielt ! inaktivert med blyacetat) ved 3 bar og romtemperatur i 12 timer. Efter frafiltrering av katalysatoren avdamper man oppløsningsmidlet og anvender det harpiksaktig, mørke residuum umiddelbart til den påfølgende omsetning. 4.2 g of 2-nitro-5-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-cinnamic acid methyl ester is hydrogenated in 100 ml of methanol with 0.5 g of Lindlar catalyst (palladium on calcium carbonate, partially inactivated with lead acetate) at 3 bar and room temperature for 12 hours. After filtering off the catalyst, the solvent is evaporated and the resinous, dark residue is used immediately for the subsequent reaction.

c) 6-[ 4-( 3, 4- diklorfenylsulfinyl)- butoksy]- karbostyril c) 6-[ 4-( 3, 4- dichlorophenylsulfinyl)-butoxy]- carbostyryl

Den i foregående trinn beskrevne 2-amino-5-[4-(3,4-diklorfenylsulfinyl)-butoksy]-kanelsyre-metylester oppvarmes med 80 ml 5N saltsyre i 3 timer til kokning og filtreres i varm tilstand. Fra filtratet utskilles farveløse krystaller ved avkjøling. The 2-amino-5-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-cinnamic acid methyl ester described in the previous step is heated with 80 ml of 5N hydrochloric acid for 3 hours until boiling and filtered while hot. Colorless crystals separate from the filtrate on cooling.

Utbytte: 2,1 g (56% av det teoretiske), smeltepunkt: 191-192°C. Yield: 2.1 g (56% of theoretical), melting point: 191-192°C.

Hvis man ved det ovenfor beskrevne reaksjonsforløp If one knows the reaction sequence described above

for reduksjonen av 2-nitro-5-[4-(3,4-diklorfenylsulfinyl)-butoksy]-kanelsyre-metylester anvender jernpulver og 80%ig eddiksyre som reduksjonsmiddel, får man likeledes 6-[4-(3,4-diklorfenylsulfinyl)-butoksy]-karbostyril som reaksjonsprodukt. for the reduction of 2-nitro-5-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-cinnamic acid methyl ester using iron powder and 80% acetic acid as a reducing agent, 6-[4-(3,4-dichlorophenylsulfinyl) is likewise obtained )-butoxy]-carbostyryl as reaction product.

E ksempel 6 Example 6

2,3 g 2-nitro-5-(3,4-diklorfenylsulfinyl)-butoksy-kanelsyre-metylester hydrogeneres i 20 ml iseddik og 0,3 g palladium/kull ved 3 bar hydrogentrykk og romtemperatur i 7 timer analogt med eksempel 5b. Derefter f raf Utreres katalysatoren, iseddiken avdestilleres, og residuet oppvarmes i 2.3 g of 2-nitro-5-(3,4-dichlorophenylsulfinyl)-butoxy-cinnamic acid methyl ester is hydrogenated in 20 ml of glacial acetic acid and 0.3 g of palladium/charcoal at 3 bar hydrogen pressure and room temperature for 7 hours analogously to example 5b. Then f raf The catalyst is removed, the glacial acetic acid is distilled off, and the residue is heated in

1 time til kokning med 40 ml 5N saltsyre. Efter avkjøling ekstraherer man med litt kloroform og foretar separering ved kromatografi på en tynnskiktplate (Merck silikagel 60 F254^ 1 hour for boiling with 40 ml of 5N hydrochloric acid. After cooling, extract with a little chloroform and separate by chromatography on a thin-layer plate (Merck silica gel 60 F254^

med etylenklorid/metanol = 9:1. Identifiseringen av de dannede forbindelser ble foretatt i UV-lys og ved besprøytning med en jod-dusj. with ethylene chloride/methanol = 9:1. The identification of the compounds formed was carried out in UV light and by spraying with an iodine shower.

Rf-verdi: 0,30: 6-[4-(3,4-diklorfenylsulfinyl)-butoksy]-karbostyril, med jod-dusj blåfiolett. Rf value: 0.30: 6-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-carbostyryl, with iodine shower blue violet.

Rf-verdi: 0,42: 6-[4-(3,4-diklorfenylmerkapto)-butoksy]-karbostyril, med jod-dusj først oransjegul, derefter gradvis gråfiolett. Rf value: 0.42: 6-[4-(3,4-dichlorophenylmercapto)-butoxy]-carbostyril, with iodine shower first orange-yellow, then gradually grey-violet.

Rf-verdi: 0,45: 6-[4-(3,4-diklorfenylsulfinyl)-butoksy]-3,4-dihydro-karbostyril, med jod-dusj kraftig oransjegul. Rf value: 0.45: 6-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-3,4-dihydro-carbostyril, with iodine shower strong orange-yellow.

Rf-verdi: 0,57: 6-[4-(3,4-diklorfenylmerkapto)-butoksy]-3,4-dihydro-karbostyril, med jod-dusj lys egg-gul. Rf value: 0.57: 6-[4-(3,4-dichlorophenylmercapto)-butoxy]-3,4-dihydro-carbostyril, with iodine shower light egg-yellow.

Eksempel 7 Example 7

6- [ 4-( 2- pyridylsulfonyl)- butoksy]- karbostyril 6- [ 4-( 2- pyridylsulfonyl)- butoxy]- carbostyryl

a) 2- nitro- 5-( 4- brombutoksy)- benzaldehyd a) 2-nitro-5-(4-bromobutoxy)-benzaldehyde

14,4 g 2-nitro-5-hydroksybenzaldehydkarbonat [F.A. Mason, 14.4 g of 2-nitro-5-hydroxybenzaldehyde carbonate [F.A. Mason,

J. Chem. Soc. 127, 119 7 (19 25)] omrøres sammen med 40 ml dibrombutan og 24 g vannfritt kaliumkarbonat i 140 ml dimetylsulfoksyd ved romtemperatur i 4 timer. Derefter fortynner man med 800 ml vann og ekstraherer reaksjonsproduktet med kloroform. Det oljeaktige avdampningsresiduum oppsluttes flere ganger med petrol-eter for å fjerne overskudd av dibrombutan. Det gjenværende oljeaktige 2-nitro-5-(4-brombutoksy)-benzaldehyd (21 g) anvendes videre i rå tilstand. J. Chem. Soc. 127, 119 7 (19 25)] is stirred together with 40 ml of dibromobutane and 24 g of anhydrous potassium carbonate in 140 ml of dimethyl sulphoxide at room temperature for 4 hours. It is then diluted with 800 ml of water and the reaction product is extracted with chloroform. The oily evaporation residue is washed several times with petroleum ether to remove excess dibromobutane. The remaining oily 2-nitro-5-(4-bromobutoxy)-benzaldehyde (21 g) is further used in the crude state.

Rf-verdi: 0,75 (tynnskiktplate (Merck silikagel 60 F 254), utviklingsmiddel: etylenklorid/metanol = 9:1). Rf value: 0.75 (thin layer plate (Merck silica gel 60 F 254), developer: ethylene chloride/methanol = 9:1).

b) 2- nitro- 5-[ 4-( 2- pyridylmerkapto)- butoksy]- benzaldehyd b) 2-nitro-5-[4-(2-pyridylmercapto)-butoxy]-benzaldehyde

21 g av det rå 2-nitro-5-(4-brombutoksy)-benzaldehyd 21 g of the crude 2-nitro-5-(4-bromobutoxy)-benzaldehyde

omrøres sammen med 11,6 g 2-merkaptopyridin og 20 g vannfritt kaliumkarbonat i 6 timer ved romtemperatur i 100 ml dimetylsulfoksyd. Man fortynner med 500 ml vann, ekstraherer med kloroform og fjerner det organiske oppløsningsmiddel i vakuum. is stirred together with 11.6 g of 2-mercaptopyridine and 20 g of anhydrous potassium carbonate for 6 hours at room temperature in 100 ml of dimethyl sulfoxide. Dilute with 500 ml of water, extract with chloroform and remove the organic solvent in vacuo.

c) 2- acetamino- 5-[ 4-( 2- pyridylsulfonyl)- butoksy]- benzaldehyd-diacetat c) 2-acetamino-5-[4-(2-pyridylsulfonyl)-butoxy]-benzaldehyde diacetate

6,6 g av det rå 2-nitro-5-[4-(2-pyridylmerkapto)-butoksy]-benzaldehyd oppvarmes sammen med 3 ml eddiksyreanhydrid og 0,01 g vannfritt sinkklorid i 30 minutter til kokning, avkjøles og omrøres med 60 ml iseddik og 2,5 g 35%ig hydrogenperoksyd i 15 timer ved romtemperatur. Reaksjonsblandingen hydrogeneres derefter i et Parr-apparat under tilsetning av 0,1 g palladium/kull ved 3 bar hydrogentrykk i 11 timer ved romtemperatur. For acetylering av den dannede aminoforbindelse inndampes reaksjonsblandingen i vakuum til tørrhet, oppvarmes påny med 20 ml eddiksyreanhydrid i 30 minutter til kokning, og blandingen av overskudd av eddiksyreanhydrid og iseddik avdestilleres. 6.6 g of the crude 2-nitro-5-[4-(2-pyridylmercapto)-butoxy]-benzaldehyde are heated together with 3 ml of acetic anhydride and 0.01 g of anhydrous zinc chloride for 30 minutes to boiling, cooled and stirred with 60 ml of glacial acetic acid and 2.5 g of 35% hydrogen peroxide for 15 hours at room temperature. The reaction mixture is then hydrogenated in a Parr apparatus with the addition of 0.1 g palladium/coal at 3 bar hydrogen pressure for 11 hours at room temperature. For acetylation of the amino compound formed, the reaction mixture is evaporated in vacuo to dryness, reheated with 20 ml of acetic anhydride for 30 minutes until boiling, and the mixture of excess acetic anhydride and glacial acetic acid is distilled off.

d) 6-[ 4-( 2- pyridylsulfonyl)- butoksy]- karbostyril d) 6-[4-(2-pyridylsulfonyl)-butoxy]-carbostyryl

Det ifølge eksempel c) erholdte destillasjonsresiduum The distillation residue obtained according to example c).

oppvarmes med 20 ml eddiksyreanhydrid og 5 g vannfritt kaliumacetat i 14 timer til kokning. Efter avkjøling tilsetter man 20 ml vann og lar blandingen stå natten over. Det utskilles farveløse krystaller. heated with 20 ml of acetic anhydride and 5 g of anhydrous potassium acetate for 14 hours until boiling. After cooling, add 20 ml of water and let the mixture stand overnight. Colorless crystals are excreted.

Utbytte: 2,9 g (41% av det teoretiske), smeltepunkt: 178-179°C. Yield: 2.9 g (41% of theoretical), melting point: 178-179°C.

Eksempel 8 Example 8

6- [ 4- ( 2- pyridylsulfonyl)- butoksy]- karbostyril 6- [ 4- ( 2- pyridylsulfonyl)- butoxy]- carbostyryl

a) 2- nitro- 5-[ 4-( 2- pyridylsulfonyl)- butoksy]- benzaldehyd a) 2-nitro-5-[4-(2-pyridylsulfonyl)-butoxy]-benzaldehyde

1,0 g av det ifølge eksempel 7b) erholdte 2-nitro-5-[4-(2-pyridylmerkapto)-butoksy]-benzaldehyd oppløses i 100 ml iseddik, tilsettes 1,0 ml 35%ig hydrogenperoksyd og omrøres i 60 timer ved romtemperatur. Man fortynner med 200 ml vann, ekstraherer med kloroform/metanol = 2:1 og får efter inndampning en olje. Utbytte: 1 g (91% av det teoretiske), 1.0 g of the 2-nitro-5-[4-(2-pyridylmercapto)-butoxy]-benzaldehyde obtained according to example 7b) is dissolved in 100 ml of glacial acetic acid, 1.0 ml of 35% hydrogen peroxide is added and stirred for 60 hours at room temperature. It is diluted with 200 ml of water, extracted with chloroform/methanol = 2:1 and, after evaporation, an oil is obtained. Yield: 1 g (91% of theoretical),

R^-verdi: 0,17 (silikagel-lysstoffplate Merck 60 F254' utviklingsmiddel: cykloheksan/etylacetat = 1:2). R^ value: 0.17 (silica gel fluorescent plate Merck 60 F254' developer: cyclohexane/ethyl acetate = 1:2).

b) 2- amino- 5-[ 4-( 2- pyridylsulfonyl)- butoksy]- benzaldehyd b) 2-amino-5-[4-(2-pyridylsulfonyl)-butoxy]-benzaldehyde

Den under a) erholdte olje reduseres med jern(II)-sulfat-heptahydrat/kons. vandig ammoniakk ved 90°C. The oil obtained under a) is reduced with iron (II) sulfate heptahydrate/conc. aqueous ammonia at 90°C.

c) 6-[ 4-( 2- pyridylsulfonyl)- butoksy]- karbostyril c) 6-[4-(2-pyridylsulfonyl)-butoxy]-carbostyryl

Det under b) erholdte 2-amino-5-[4-(2-pyridylsulfonyl)-butoksy]-benzaldehyd acetyleres med eddiksyreanhydrid/pyridin, opptas pånytt i eddiksyreanhydrid og oppvarmes med vannfritt kaliumacetat i 5 timer ved kokning under tilbakeløpskjøling. Man fortynner med vann efter avkjøling og ekstraherer med kloroform/metanol = 2:1. Inndampningsresiduet krystalliserer efter en tid. Omkrystallisering foretas fra xylen under tilsetning av litt dimetylformaldehyd. The 2-amino-5-[4-(2-pyridylsulfonyl)-butoxy]-benzaldehyde obtained under b) is acetylated with acetic anhydride/pyridine, taken up again in acetic anhydride and heated with anhydrous potassium acetate for 5 hours by boiling under reflux. Dilute with water after cooling and extract with chloroform/methanol = 2:1. The evaporation residue crystallizes after some time. Recrystallization is carried out from xylene with the addition of a little dimethylformaldehyde.

Smeltepunkt: 179-181°C. Melting point: 179-181°C.

Analogt med de ovenstående eksempler ble følgende forbindelser fremstilt: 6-(4-fenylmerkapto-butoksy)-3,4-dihydrokarbostyril, smeltepunkt: 121,5-12 3°C 6-(4-fenylsulfinylbutoksy)-3,4-dihydrokarbostyril, smeltepunkt: 144,5-145,5°C, Analogous to the above examples, the following compounds were prepared: 6-(4-phenylmercapto-butoxy)-3,4-dihydrocarbostyril, melting point: 121.5-12 3°C 6-(4-phenylsulfinylbutoxy)-3,4-dihydrocarbostyryl, melting point: 144.5-145.5°C,

6-(4-fenylsulfonylbutoksy)-3,4-dihydrokarbostyril, smeltepunkt: 157,5-158°C, 6-(4-phenylsulfonylbutoxy)-3,4-dihydrocarbostyryl, melting point: 157.5-158°C,

6-[4-(2-pyridylmerkapto)-butoksy]-3,4-dihydrokarbostyril, smeltepunkt: 123-124,5°C, 6-[4-(2-pyridylmercapto)-butoxy]-3,4-dihydrocarbostyryl, melting point: 123-124.5°C,

6-[4-(2-pyridylsulfiny1)-butoksy]-3,4-dihydrokarbostyril, smeltepunkt: 144,5-146°C, 6-[4-(2-pyridylsulfinyl)-butoxy]-3,4-dihydrocarbostyryl, melting point: 144.5-146°C,

6-[4-(2-pyridylsulfonyl)-butoksy]-3,4-dihydrokarbostyril, smeltepunkt: 123,8-125°C, 6-[4-(2-pyridylsulfonyl)-butoxy]-3,4-dihydrocarbostyryl, melting point: 123.8-125°C,

6-(2-fenylsulfinyl-etoksy)-3,4-dihydrokarbostyril, smeltepunkt: 171-172°C, 6-(2-phenylsulfinyl-ethoxy)-3,4-dihydrocarbostyril, melting point: 171-172°C,

6-(4-benzylsulfiny1-butoksy)-3,4-dihydrokarbostyril, smeltepunkt: 141,5-142°C, 6-(4-benzylsulfinyl-butoxy)-3,4-dihydrocarbostyryl, melting point: 141.5-142°C,

6-[4-(4-klorfenylsulfinyl)-butoksy]-3,4-dihydrokarbostyril, smeltepunkt: 148-149,5°C, 6-[4-(4-chlorophenylsulfinyl)-butoxy]-3,4-dihydrocarbostyryl, melting point: 148-149.5°C,

6-(4-cykloheksylsulfiny1-butoksy)-3,4-dihydrokarbostyril, smeltepunkt: 153-155,5°C, 6-(4-cyclohexylsulfinyl-1-butoxy)-3,4-dihydrocarbostyryl, melting point: 153-155.5°C,

6-[4-(2-naftylsulfinyl)-butoksy]-3,4-dihydrokarbostyril, smeltepunkt: 147,5-148,5°C, 6-[4-(2-naphthylsulfinyl)-butoxy]-3,4-dihydrocarbostyryl, melting point: 147.5-148.5°C,

6-[4-(2-metoksyfenylsulfinyl)-butoksy]-3,4-dihydrokarbostyril, smeltepunkt: 130,5-133°C, 6-[4-(2-Methoxyphenylsulfinyl)-butoxy]-3,4-dihydrocarbostyril, melting point: 130.5-133°C,

6- (4-fenylsulfiny1-butoksy)-karbostyril, 6-(4-phenylsulfinyl-1-butoxy)-carbostyryl,

smeltepunkt: 181-182,5°C, melting point: 181-182.5°C,

6-[4-(4-hydroksy-3,5-di-tert.butyl-fenylsulfinyl)-butoksy]karbostyril 6-[4-(4-hydroxy-3,5-di-tert.butyl-phenylsulfinyl)-butoxy]carbostyryl

smeltepunkt: 19 2-19 4°C, melting point: 19 2-19 4°C,

6-[4-(3,4-dikiorfenylsulfinyl)-butoksy]-karbostyril, smeltepunkt: 191-196°C, 6-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-carbostyryl, melting point: 191-196°C,

4-metyl-6-(4-fenylsulfiny1-butoksy)-karbostyril, 4-methyl-6-(4-phenylsulfinyl-butoxy)-carbostyril,

smeltepunkt: 167-168°C, melting point: 167-168°C,

6-[4-(3,4-diklorfenylsulfony1)-butoksy]-3,4-dihydrokarbostyril, smeltepunkt: 172-173°C, 6-[4-(3,4-dichlorophenylsulfonyl)-butoxy]-3,4-dihydrocarbostyryl, melting point: 172-173°C,

6-[4-(2,5-diklorfenylsulfinyl)-butoksy]-3,4-dihydrokarbostyril, smeltepunkt: 185-186°C, 6-[4-(2,5-dichlorophenylsulfinyl)-butoxy]-3,4-dihydrocarbostyryl, melting point: 185-186°C,

6-[4-(2-pyridyl)-sulfony1-butoksy]-karbostyril, 6-[4-(2-pyridyl)-sulfony-1-butoxy]-carbostyryl,

smeltepunkt: 179-180°C, melting point: 179-180°C,

6-[4-(2-naftyl-sulfinyl)-butoksy]-3,4-dihydro-karbostyril, smeltepunkt: 147,5-148,5°C, 6-[4-(2-naphthyl-sulfinyl)-butoxy]-3,4-dihydro-carbostyryl, melting point: 147.5-148.5°C,

6- [4- (4-bifenylylsulfinyl)-butoksy]-karbostyril, 6-[4-(4-biphenylylsulfinyl)-butoxy]-carbostyryl,

smeltepunkt: 196-197°C, melting point: 196-197°C,

6-[4-(2-kinolylsulfinyl)-butoksy]-karbostyril, 6-[4-(2-quinolylsulfinyl)-butoxy]-carbostyril,

smeltepunkt: 19 7-19 8°C, melting point: 19 7-19 8°C,

6- [4-cykloheksylsulfinyl)-butoksy]-karbostyril, 6-[4-cyclohexylsulfinyl)-butoxy]-carbostyryl,

smeltepunkt: 169-170°C, melting point: 169-170°C,

5- brom-6-(4-fenylsulfiny1-butoksy)-karbostyril, 5-bromo-6-(4-phenylsulfinyl-butoxy)-carbostyryl,

smeltepunkt: 190-191°C, melting point: 190-191°C,

6- [2-(N-metyl-N-cykloheksyl-karbamidometyl-sulfinyl)-etoksy]-karbostyril, 6-[2-(N-methyl-N-cyclohexyl-carbamidomethyl-sulfinyl)-ethoxy]-carbostyryl,

smeltepunkt: 123-130°C, melting point: 123-130°C,

6-[4-(3,5-dibrom-4-aminofenylsulfinyl)-butoksy]-3,4-dihydrokarbostyril , 6-[4-(3,5-dibromo-4-aminophenylsulfinyl)-butoxy]-3,4-dihydrocarbostyryl,

smeltepunkt: 144-146°C, melting point: 144-146°C,

6-[4-(3,5-dibrom-4-aminofenylsulfinyl)-butoksy]-karbostyril, smeltepunkt: 205-207°C, 6-[4-(3,5-dibromo-4-aminophenylsulfinyl)-butoxy]-carbostyryl, melting point: 205-207°C,

6- [4- (3,4-cykloheksylfenylsulfinyl)-butoksy]-3,4-dihydrokarbostyril, 6-[4-(3,4-cyclohexylphenylsulfinyl)-butoxy]-3,4-dihydrocarbostyryl,

smeltepunkt: 155-157°C, melting point: 155-157°C,

6-[4-(4-cykloheksylfenylsulfinyl)-butoksy]-karbostyril, smeltepunkt: 188-190°C, 6-[4-(4-cyclohexylphenylsulfinyl)-butoxy]-carbostyryl, melting point: 188-190°C,

6-[4-(4-tert.butylfenylsulfinyl)-butoksy]-karbostyril,• smeltepunkt: 16 4-16 6°C, 6-[4-(4-tert.butylphenylsulfinyl)-butoxy]-carbostyryl,• melting point: 16 4-16 6°C,

6- [4- (3,4-diklorfenylsulfinyl)-butoksy]-3,4-dihydrokarbostyril, smeltepunkt: 106,5-108°C, 6-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-3,4-dihydrocarbostyryl, melting point: 106.5-108°C,

smeltepunkt: 148-149°C ( 1 x fra toluen og 1 x fra etanol). melting point: 148-149°C (1 x from toluene and 1 x from ethanol).

Claims (1)

Analogifremgangsmåte for fremstilling av terapeutisk aktive karbostyrilderivater som angitt i patent 152839 med den generelle formelAnalogous process for the preparation of therapeutically active carbostyryl derivatives as set forth in patent 152839 with the general formula hvorwhere W betyr en eventuelt med en metylgruppe substituert vinylenW means a optionally substituted vinylene with a methyl group gruppe eller en etylengruppe,group or an ethylene group, m betyr tallet 0, 1 eller 2,m means the number 0, 1 or 2, D betyr en lineær alkylengruppe med 2 til 6 karbonatomer, enD means a linear alkylene group of 2 to 6 carbon atoms, a 2-hydroksy-n-propylengruppe eller en xylylengruppe, 1*2 betyr en cykloheksyl-, benzyl-, naftyl-, pyridyl-, pyrimidyl-, 1,2,4-triazolyl-, pyridy1-oksyd-, furfuryl-, trifenylmetyl-,2-hydroxy-n-propylene group or a xylylene group, 1*2 means a cyclohexyl, benzyl, naphthyl, pyridyl, pyrimidyl, 1,2,4-triazolyl, pyridyloxide, furfuryl, triphenylmethyl , kinolyl-, benzimidazolyl-, benztiazolyl-, kinazolin-4-on-yl-, 4,5-bis-(p-klorfenyl)-oksazol-2-yl-, N-metyl-N-cykloheksylamino-karbonylmetyl- eller aminoiminometylgruppe, en eventuelt med en karboksyl-, hydroksy-, metoksy-, amino-, acetylamino-, nitro-, cykloheksyl- eller fenylgruppe substituert fenylgruppe,quinolyl, benzimidazolyl, benzthiazolyl, quinazolin-4-on-yl, 4,5-bis-(p-chlorophenyl)oxazol-2-yl, N-methyl-N-cyclohexylaminocarbonylmethyl or aminoiminomethyl group, a phenyl group optionally substituted with a carboxyl, hydroxy, methoxy, amino, acetylamino, nitro, cyclohexyl or phenyl group, en med halogenatomer og/eller alkylgrupper med 1-4 karbonatomer mono- eller disubstituert fenylgruppe, en med to halogenatomer eller med to alkylgrupper med 1-4 karbonatomer substituert hydroksyfenyl-, halogenfenyl- eller aminofenylgruppe, R^ betyr et hydrogen- eller bromatom eller en acetylamino- ellerone with halogen atoms and/or alkyl groups with 1-4 carbon atoms mono- or disubstituted phenyl group, one with two halogen atoms or with two alkyl groups with 1-4 carbon atoms substituted hydroxyphenyl, halophenyl or aminophenyl group, R^ means a hydrogen or bromine atom or a acetylamino- or nitrogruppe, ognitro group, and resten Ro-S0 -D-0- er i 6- eller 7-stilling, karakterisert ved at a) en eventuelt i reaksjonsblandingen dannet forbindelsethe remainder Ro-S0 -D-0- is in the 6- or 7-position, characterized by a) a compound possibly formed in the reaction mixture med den generelle formelwith the general formula hvor D, w, , R. og m er som ovenfor angitt, og Z betyr en nukleofil, avspaltbar gruppe så som en hydroksygruppe, et halogenatom, en alkoksy-, aryloksy- eller aralkyloksygruppe, ringsluttes, eller" b) for fremstilling av en forbindelse med den generelle formel I hvor m betyr tallet 2, omsettes et karbostyril med den generelle formelwhere D, w, , R. and m are as indicated above, and Z means a nucleophilic, leaving group such as a hydroxy group, a halogen atom, an alkoxy, aryloxy or aralkyloxy group, is ring-closed, or" b) for the preparation of a connection with the general formula I where m means the number 2, a carbostyril with the general formula is reacted hvor D, W og R, er som ovenfor angitt, og Y betyr en nukleofil, avspaltbar gruppe så som et halogenatom eller en sulfonsyreester-rest, med et metallsalt med den generelle formelwhere D, W and R are as above, and Y means a nucleophilic leaving group such as a halogen atom or a sulphonic acid ester residue, with a metal salt of the general formula hvor R2 er som ovenfor angitt, og Me betyr et alkali-metallatom, og Me^ betyr et jordalkali-metallatom, eller c) for fremstilling av en forbindelse med den generelle formel I hvor W er en vinylengruppe og m tallet 0 eller 2, ringsluttes en eventuelt i reaksjonsblandingen dannet forbindelse med den generelle formelwhere R2 is as indicated above, and Me means an alkali metal atom, and Me^ means an alkaline earth metal atom, or c) for the preparation of a compound of the general formula I where W is a vinylene group and m the number 0 or 2, ring closure an optionally formed compound of the general formula in the reaction mixture hvor , R^, D og m er som ovenfor angitt, eller et acetal derav.where , R^, D and m are as indicated above, or an acetal thereof.
NO792659A 1979-07-14 1979-08-15 ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOSTYRIC DERIVATIVES. NO154131C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792928583 DE2928583A1 (en) 1979-07-14 1979-07-14 Substd. alkoxy-carbostyril derivs prodn. - e.g. by cyclising 2-carboxyethyl-1-aminobenzene derivs., useful as antithrombotic and positive inotropic agents

Publications (3)

Publication Number Publication Date
NO792659L NO792659L (en) 1981-01-15
NO154131B true NO154131B (en) 1986-04-14
NO154131C NO154131C (en) 1986-07-23

Family

ID=6075786

Family Applications (1)

Application Number Title Priority Date Filing Date
NO792659A NO154131C (en) 1979-07-14 1979-08-15 ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOSTYRIC DERIVATIVES.

Country Status (5)

Country Link
JP (1) JPS5616470A (en)
DE (1) DE2928583A1 (en)
DK (1) DK150156C (en)
FI (1) FI70408C (en)
NO (1) NO154131C (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI77852C (en) * 1981-02-17 1989-05-10 Otsuka Pharma Co Ltd Process for the preparation of novel, such as cardiac drugs, useful s unsubstituted amide and (saturated heterocycle) carbonyl carbostyril derivatives.
US4442111A (en) * 1981-07-25 1984-04-10 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Antithrombotic sulfimino and sulfoximino indolinones-2
AU532361B2 (en) * 1981-09-01 1983-09-29 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
DK167187A (en) * 1986-04-02 1987-10-03 Otsuka Pharma Co Ltd CARBOSTYRIC DERIVATIVES AND SALTS THEREOF, PROCEDURE FOR THE PREPARATION OF SUCH COMPOUNDS AND MEDICINAL CONTAINING THESE
KR940000785B1 (en) * 1986-04-02 1994-01-31 오오쓰까세이야꾸 가부시끼가이샤 Process for the preparation of carbostyril derivatives and salts thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5321176A (en) * 1976-08-09 1978-02-27 Otsuka Pharmaceut Co Ltd Carbostyryl derivatives

Also Published As

Publication number Publication date
DK150156C (en) 1987-10-12
NO154131C (en) 1986-07-23
NO792659L (en) 1981-01-15
FI70408B (en) 1986-03-27
FI70408C (en) 1986-09-19
FI792426A (en) 1981-01-15
DE2928583A1 (en) 1981-01-29
JPS6326751B2 (en) 1988-05-31
DK342079A (en) 1981-01-15
DK150156B (en) 1986-12-22
JPS5616470A (en) 1981-02-17

Similar Documents

Publication Publication Date Title
US4066651A (en) Alkanoic acid 2-quinoline derivatives
PL170726B1 (en) Method of obtaining 2-substituted quinolines
NO154131B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOSTYRIC DERIVATIVES.
NO164351B (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5-ALKYL-L-PHENYL-2-PIPERAZINOALKYLPYRAZOLINE-3-ON COMPOUNDS.
JPH0692371B2 (en) Novel heterocyclic derivative, method for producing the same, and method for producing a medicine containing these and particularly useful as an aldose reductase inhibitor
CS236876B2 (en) Processing of new dibenzoxazine
NO158185B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,5-DIFENYLPYRAZOLINE-3-ON COMPOUNDS.
NO814468L (en) TIAZOLINE DERIVATIVES, PROCEDURES FOR THEIR PREPARATION, THEIR USE, AND PHARMACEUTICAL PREPARATIONS BASED ON THESE COMPOUNDS
US2558211A (en) Preparation of 4-hydroxyquinoline compounds
US4138490A (en) Analgesic compositions containing 1,2-dihydro-2-oxoquinol-4-ylpropionic acid derivatives
US4555513A (en) 1,2 Dihydro- and 1,2,3,4-tetrahydro quinolylacetic acids and analgesic use thereof
NO158184B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC EFFECTIVE 1-PHENYLINDAZOL-3-ON COMPOUNDS AND THEIR SALTS.
US2139570A (en) Thiazole compounds and manufacture thereof
US2554186A (en) Para-amino hydroxybenzamides
US2996512A (en) Therapeutic derivatives of aryl-
Unangst et al. 2‐Indolyl ketone synthesis
US2187847A (en) Condensation products of butyrolactones and primary amines of the aromatic and heterocyclic series
LEVITZ et al. The Search for Superior Drugs for Tropical Diseases. I. Derivatives of Quininaldehyde and 6, 7-Dimethoxycinchoninaldehyde
KR840002103B1 (en) Process for preparing carbostyril derivatives
Devereux et al. N-Substituted imides. ii. Potassium Naphthalimide as a Reagent for the identification of Alkyl Halides
Allen et al. Heterocyclic fluorine compounds. Part II. Bz-Monofluoroindoles
Souza et al. On the application of knoevenagel condensation for the synthesis of benzylidene benzothiazine compounds and structural study
US2030373A (en) Derivatives of thiazole and process of preparing the same
NO125927B (en)
US2695297A (en) N-pyridoxyl-amines